Lmcg Investments LLC Has $4.98 Million Stake in Inspire Medical Systems, Inc. (NYSE:INSP)

Lmcg Investments LLC lowered its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 12.2% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 26,868 shares of the company’s stock after selling 3,741 shares during the period. Lmcg Investments LLC owned approximately 0.09% of Inspire Medical Systems worth $4,981,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in INSP. True Wealth Design LLC acquired a new position in shares of Inspire Medical Systems in the 3rd quarter valued at $30,000. Farther Finance Advisors LLC boosted its holdings in Inspire Medical Systems by 1,158.3% during the third quarter. Farther Finance Advisors LLC now owns 151 shares of the company’s stock valued at $32,000 after purchasing an additional 139 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Inspire Medical Systems by 559.3% in the 3rd quarter. GAMMA Investing LLC now owns 178 shares of the company’s stock worth $38,000 after buying an additional 151 shares in the last quarter. Signaturefd LLC boosted its stake in Inspire Medical Systems by 45.9% in the 3rd quarter. Signaturefd LLC now owns 270 shares of the company’s stock valued at $57,000 after buying an additional 85 shares in the last quarter. Finally, Quarry LP lifted its holdings in shares of Inspire Medical Systems by 105.4% during the second quarter. Quarry LP now owns 343 shares of the company’s stock valued at $46,000 after acquiring an additional 176 shares during the period. Institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Stock Up 2.4 %

Inspire Medical Systems stock opened at $177.97 on Tuesday. The company has a 50 day moving average of $189.18 and a 200-day moving average of $185.41. Inspire Medical Systems, Inc. has a twelve month low of $123.00 and a twelve month high of $257.40. The stock has a market capitalization of $5.33 billion, a PE ratio of 166.33 and a beta of 1.32.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. The company had revenue of $203.20 million for the quarter, compared to the consensus estimate of $197.59 million. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The firm’s revenue was up 32.6% compared to the same quarter last year. During the same period last year, the company earned ($0.29) earnings per share. Equities analysts anticipate that Inspire Medical Systems, Inc. will post 1.34 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently weighed in on INSP. Bank of America raised shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $220.00 to $255.00 in a report on Wednesday, November 20th. Stifel Nicolaus reiterated a “hold” rating and issued a $200.00 price objective (up previously from $170.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Robert W. Baird increased their target price on Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a report on Tuesday, November 5th. Wells Fargo & Company lifted their price target on Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a report on Tuesday, November 5th. Finally, Truist Financial reissued a “buy” rating and set a $240.00 price objective (up previously from $217.00) on shares of Inspire Medical Systems in a report on Monday, September 30th. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, Inspire Medical Systems has a consensus rating of “Moderate Buy” and an average price target of $232.55.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.